Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00069992
Status:
TERMINATED
Last Update Posted:
2012-10-10
First Post:
2003-10-03
Brief Title:
Total-Body Irradiation Fludarabine and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder MS AML or CML
Sponsor:
Baylor College of Medicine
Organization:
Baylor College of Medicine
Organization Data
Organization:
Baylor College of Medicine
Class:
OTHER
Study ID:
H-10857-MPDMDSBMT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baylor College of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
George Carrum
Responsible Party Title:
Associate Professor Director-Adult Outpatient Clinic
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Baylor College of Medicine
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Center for Cell and Gene Therapy Baylor College of Medicine | OTHER |
| The Methodist Hospital Research Institute | OTHER |